m. jennifer abuzzahab,md 1 june 2012 evaluating and managing precocious puberty and pcos

44
M. Jennifer Abuzzahab,MD 1 June 2012 Evaluating and Managing Precocious Puberty and PCOS

Upload: jaycee-blue

Post on 02-Apr-2015

223 views

Category:

Documents


4 download

TRANSCRIPT

Page 1: M. Jennifer Abuzzahab,MD 1 June 2012 Evaluating and Managing Precocious Puberty and PCOS

M. Jennifer Abuzzahab,MD1 June 2012

Evaluating and Managing Precocious

Puberty and PCOS

Page 2: M. Jennifer Abuzzahab,MD 1 June 2012 Evaluating and Managing Precocious Puberty and PCOS

Disclosures

I have no relevant financial relationships to disclose.

I will be discussing off label use of medications.

Page 3: M. Jennifer Abuzzahab,MD 1 June 2012 Evaluating and Managing Precocious Puberty and PCOS

Objectives

Recognize the normal timing and cadence of pubertal developmentDescribe the role of insulin in steroidogenesisIdentify when to refer to a specialist

Page 4: M. Jennifer Abuzzahab,MD 1 June 2012 Evaluating and Managing Precocious Puberty and PCOS

Definitions

Adrenarche (Pubarche)Pubic or axillary hairPremature adrenarche (<8yo girls, <9yo boys)

Gonadarche (Puberty)LH/FSH activation of gonadsGender specific sex-steroid production

PCOSOvarian HyperandrogenismIncreased testosterone production (females)Can not occur until after onset of puberty

Page 5: M. Jennifer Abuzzahab,MD 1 June 2012 Evaluating and Managing Precocious Puberty and PCOS

Precocious Puberty

BMI major consideration in evaluation of puberty prior to age 8Breast development can be seen in girls as young as 7 depending on ethnicity and BMIPubic hair prior to 8y in girls and 10y in boys is premature IF BMI is <85%

Rosenfield RL, Pediatrics 2009 ;123(1):84-88.

Page 6: M. Jennifer Abuzzahab,MD 1 June 2012 Evaluating and Managing Precocious Puberty and PCOS

Steroidogenesis

Role of LeptinEnhances 17,20 Lyase activityIncreases androstenedioneIncreases DHEA-S

Role of InsulinIncreases ACTH-mediated steroidogenesisCo-gonadotrophic effect on theca cellLink between premature adrenarche and PCOS

Page 7: M. Jennifer Abuzzahab,MD 1 June 2012 Evaluating and Managing Precocious Puberty and PCOS

Case 7 4/12 yo boy referred for early pubertal development

adult type body odor for two years, pubic hair development for 6-8 months

diet recall shows excessive portions at every meal and breakfast both at home and school

family history for type 2 Diabetes Mellitus in multiple family members

PE remarkable for height above mid parental target, obesity, Tanner 2 pubic hair, scrotal thinning, 2 cc testes, apocrine secretions but no axillary hair

lab tests: Bone age 9 years, adrenal precursors slightly elevated, testosterone & LH/FSH prepubertal

diet and exercise regimen started, attempt to get whole family involved

Page 8: M. Jennifer Abuzzahab,MD 1 June 2012 Evaluating and Managing Precocious Puberty and PCOS

Xenobiotics

Endocrine disruptors Mimic natural hormone binding

phthalates BPA phyto-estrogens

soy lavender oil tea tree oil

Page 9: M. Jennifer Abuzzahab,MD 1 June 2012 Evaluating and Managing Precocious Puberty and PCOS

Xenobiotics

                                                              

phthalates

Tea tree oil Linalool

Lavendula acetate

Page 10: M. Jennifer Abuzzahab,MD 1 June 2012 Evaluating and Managing Precocious Puberty and PCOS

Xenobiotics

                                                              

Bisphenol A

Triclocarban

Page 11: M. Jennifer Abuzzahab,MD 1 June 2012 Evaluating and Managing Precocious Puberty and PCOS

BPA Estrogen mimeticMice fed high BPA become obese

PhthalatesHigher levels found in obese men/womenLinked to insulin resistance

Insecticides/herbicides/antifungals and many antibacterial soaps

EstrogenicPotentiate steroid effects at receptor level

Xenobiotics

Page 12: M. Jennifer Abuzzahab,MD 1 June 2012 Evaluating and Managing Precocious Puberty and PCOS

Case Presentation

3-11/12 yo girl with 6 months of breast development

Term infant, 7# 10oz No known exposures Rapid height gain over past year,

without significant change in weight PE: Tanner 3 breast, Tanner 1

pubic hair

Page 13: M. Jennifer Abuzzahab,MD 1 June 2012 Evaluating and Managing Precocious Puberty and PCOS

Case Presentation

Page 14: M. Jennifer Abuzzahab,MD 1 June 2012 Evaluating and Managing Precocious Puberty and PCOS

Case Presentation

Bone Age advanced at 5y9m Estradiol <15ng/dL GnRH stimulation testing revealed

no rise in LH/FSH or estrogen pelvic ultrasound revealed

prepubertal ovaries, no cysts, uterine enlargement

Endocrine RN noted glitter “all over” patient at time of stim test

Page 15: M. Jennifer Abuzzahab,MD 1 June 2012 Evaluating and Managing Precocious Puberty and PCOS

Case Presentation

Page 16: M. Jennifer Abuzzahab,MD 1 June 2012 Evaluating and Managing Precocious Puberty and PCOS

Choose plastics 1,2,4 or 5Use stainless steel or glass bottlesConsider alternatives to canned foods

FreshFrozenGlass

Avoid microwaving in plastic

Xenobiotics

Page 17: M. Jennifer Abuzzahab,MD 1 June 2012 Evaluating and Managing Precocious Puberty and PCOS

Avoid phthalatesVinyl toysVinyl shower curtainsGlitter body products

Diethyl phthalates are “scent enhancers”

Certain air-freshenersLook for fragrance free personal care products, detergents, cleansers

Xenobiotics

Page 18: M. Jennifer Abuzzahab,MD 1 June 2012 Evaluating and Managing Precocious Puberty and PCOS

Premature Adrenarche

Fetal programminggirls with low birth weight (-1.5SD) predisposed to insulin resistancerapid pubertal progressionearly-normal menarche

Ibanez, L. JCEM 1993;76:1599

Page 19: M. Jennifer Abuzzahab,MD 1 June 2012 Evaluating and Managing Precocious Puberty and PCOS

Premature AdrenarcheHistory and Physical Exam

Birth historyTanner staging

Laboratory Evaluations17-OHP, Androstenedione, DHEA-S, consider TestosteroneLH/FSHConsider Estradiol

Radiologic EvaluationBone Age1-2 year advance expected

Page 20: M. Jennifer Abuzzahab,MD 1 June 2012 Evaluating and Managing Precocious Puberty and PCOS

Case Presentation

nearly 5 yo girl with BO for 2 years, breasts for 1-2 monthsattends preschool, keeps up with her peers. Mood swings and some flirtatious behavior over the past 6 months. Term infant 7#,4 oz (AGA), adopted at 11 days of age. no hormone or body building supplement exposuresHt 118.4 cm (+2.2 SD), Wt 25.4 kg (+2 SD), BMI 18.1 (95%), T2 breasts (flat disks of acinar tissue) with T3 contour, T1 pubic hair (fine, dark hairs across mons pubis), prepubertal labia. no axillary hair, very light apocrine secretions.

Page 21: M. Jennifer Abuzzahab,MD 1 June 2012 Evaluating and Managing Precocious Puberty and PCOS

Case Presentation

Page 22: M. Jennifer Abuzzahab,MD 1 June 2012 Evaluating and Managing Precocious Puberty and PCOS

Case Presentation

AGA infant, not at higher risk for precocious puberty, type 2 DM or PCOS.BA only 1.5 years advancedAdrenal precursors normalBreast tissue from peripheral conversion to EstroneFollowing clinically as slightly higher risk for true central precocious puberty.

Page 23: M. Jennifer Abuzzahab,MD 1 June 2012 Evaluating and Managing Precocious Puberty and PCOS

Premature Adrenarche

Metformin treatment for girls with LBW and PALess insulin resistanceLess androgen excessLess atherogenic lipid profileAltered body composition

BMI 19.5 vs 20.3Fat 13.1kg vs 16.1kgLean 25.8kg vs 24.8kg

Menarche one year later in treated group

Ibanez, L. JCEM 91:2888-2891, 2006.

Page 24: M. Jennifer Abuzzahab,MD 1 June 2012 Evaluating and Managing Precocious Puberty and PCOS

Premature AdrenarcheMetformin therapy may be indicated for girls

with LBW and premature adrenarchePrevents earlier steps in the cascade from LBW infant to early puberty and menarche, obese BMI and IR/PCOSNormalizes pubertal progression and growth in this populationMay attenuate the activity of the GnRH pulse generator and enhance gonadal feedback on LH secretionInsulin has effects far beyond glucose metabolism

Page 25: M. Jennifer Abuzzahab,MD 1 June 2012 Evaluating and Managing Precocious Puberty and PCOS

Insulin Resistance

PseudoacromegalyBlunted pubertal growth spurtPremature AdrenarchePubertal delay in malesPCOS

M De Simone. Int J Obes Relat Metab Disord. 1995 Dec;19(12):851-7M Vignolo. Eur J Pediatr. 1999 Apr; 147(3):242-4.

Page 26: M. Jennifer Abuzzahab,MD 1 June 2012 Evaluating and Managing Precocious Puberty and PCOS

Insulin Resistance

Mantazoros CS, Flier JS, Adv Endo Metab 1995;6:193

Page 27: M. Jennifer Abuzzahab,MD 1 June 2012 Evaluating and Managing Precocious Puberty and PCOS

Case

13-9/12yo girl menarche at age 10 Irregular menses and increased

acne for one year Significant weight gain over past

two years Strong family history for type 2

diabetes Many female family members with

“thyroid condition”

Page 28: M. Jennifer Abuzzahab,MD 1 June 2012 Evaluating and Managing Precocious Puberty and PCOS

Case

PE: obesity, acanthosis nigricans, T5 breast, T5 pubic hair in male estucheon, moderate acne face/chest, prominent sideburns

Adrenal precursors normal freeTestosterone elevated at 7.6

total testosterone 65 Estradiol 72 LH/FSH normal

Page 29: M. Jennifer Abuzzahab,MD 1 June 2012 Evaluating and Managing Precocious Puberty and PCOS

Case

Page 30: M. Jennifer Abuzzahab,MD 1 June 2012 Evaluating and Managing Precocious Puberty and PCOS

Polycystic Ovarian Syndrome

Virilization Hirsutism Amenorrhea/Oligomenorrhea Infertility

Page 31: M. Jennifer Abuzzahab,MD 1 June 2012 Evaluating and Managing Precocious Puberty and PCOS

Adolescent females Need not have cysts Need not have LH > FSH Must be differentiated from Adrenal Disease Exaggerated Adrenarche is a harbinger of PCOS after menarche

Polycystic Ovarian Syndrome

Page 32: M. Jennifer Abuzzahab,MD 1 June 2012 Evaluating and Managing Precocious Puberty and PCOS

Diet and Activity HistoryLaboratory Evaluations

Free TestosteroneSex Hormone Binding GlobulinAdrenal Precursors

Androstenedione17 OH ProgesteroneDHEAS

Two hour post-prandial glucose and insulin

Polycystic Ovarian Syndrome

Page 33: M. Jennifer Abuzzahab,MD 1 June 2012 Evaluating and Managing Precocious Puberty and PCOS

TreatmentDiet and ExerciseOral Contraceptives

low androgenic progesterone (desogestrel) low-estrogen pills not sufficient to supress Testosterone production

SpironolactoneMetformin

Polycystic Ovarian Syndrome

Page 34: M. Jennifer Abuzzahab,MD 1 June 2012 Evaluating and Managing Precocious Puberty and PCOS

Oral contraceptivesChose low bio-available progesterone

DesogenOrtho-cyclen

Increases estrogen and SHBGDecreases FSH and LH by negative feedbackDecreases all steroid production by the ovaryIdiosyncratic elevation of cholesterol in 5% of women on OCPNew “low” estrogen products not sufficient for teens or PCOS

Polycystic Ovarian Syndrome

Page 35: M. Jennifer Abuzzahab,MD 1 June 2012 Evaluating and Managing Precocious Puberty and PCOS

Ovarian steroidogenesis

LH

FSH

Thecal Cell

Granulosa Cell

Cholesterol

Pregnenolone Progesterone

17OH-Progesterone

Androstenedione

Testosterone

Estrone

Estradiol

InhibinInsulinIGF-1

++-

--

+

+

Page 36: M. Jennifer Abuzzahab,MD 1 June 2012 Evaluating and Managing Precocious Puberty and PCOS

Ovarian steroidogenesis

LH

FSH

Thecal Cell

Granulosa Cell

Cholesterol

Pregnenolone Progesterone

17OH-Progesterone

Androstenedione

Testosterone

Estrone

Estradiol

InhibinInsulinIGF-1

++-

--

+

+

Page 37: M. Jennifer Abuzzahab,MD 1 June 2012 Evaluating and Managing Precocious Puberty and PCOS

Ovarian steroidogenesis

LH

FSH

Thecal Cell

Granulosa Cell

Cholesterol

Pregnenolone Progesterone

17OH-Progesterone

Androstenedione

Testosterone

Estrone

Estradiol

InhibinInsulinIGF-1

++-

--

+

+

Page 38: M. Jennifer Abuzzahab,MD 1 June 2012 Evaluating and Managing Precocious Puberty and PCOS

Biguanides (Metformin)Reduces free testosterone levelsInduces normal ovulatory cycles in 91% of women with PCOSMust consider need for contraception in adolescent population

Gluek, et al. Metabolism, 48(4),1999. 511

Polycystic Ovarian Syndrome

Page 39: M. Jennifer Abuzzahab,MD 1 June 2012 Evaluating and Managing Precocious Puberty and PCOS

Biguanides (Metformin)Decreases hepatic glucose outputIncreases hepatic and muscle sensitivity to insulinStart low, 250mg with dinner

slow increase to goal 1500-2000mg may change to XR

Side effects: anorexia, weight loss, abdominal pain, diarrheaRisk of lactic acidosis, Vit B12 deficiencyCheck renal panel, start MVI

Polycystic Ovarian Syndrome

Page 40: M. Jennifer Abuzzahab,MD 1 June 2012 Evaluating and Managing Precocious Puberty and PCOS

Growth Case 14 4/12 yo girl referred for irregular periods Breast development at 11, menarche at 13 Irregular periods: cycles 21- 45d, 3-9d menses rapid weight gain over past year (20#) skips breakfast, otherwise reasonable diet Birth history: term infant 5# 8 ounces FHX: type 2 DM mgm, pgm, HTN pgf BMI 26.2 (90%), light mustache, mild

acanthosis nigricans Laboratory evaluations

adrenal precursors normal free testosterone 3.7% (0.8-1.4) SHBG 0.1 (1 - 3) fasting insulin 12, glucose 64 cholesterol 160

Page 41: M. Jennifer Abuzzahab,MD 1 June 2012 Evaluating and Managing Precocious Puberty and PCOS

Growth Case

Page 42: M. Jennifer Abuzzahab,MD 1 June 2012 Evaluating and Managing Precocious Puberty and PCOS

Case 15 1/2 yo Hmong girl concerned about

excessive acne skips breakfast, very light lunch,

concentrates calories at the end of the day sedentary lifestyle: “lots of homework”,

babysitting breast development at 10 y, no menarche BMI 33 Acanthosis Nigricans, acne, skin tags,

hirsute, mild clitoromegaly (2.2 cm x 0.8 cm)

testosterone elevated, adrenal normal, glucose 211, insulin 296

Page 43: M. Jennifer Abuzzahab,MD 1 June 2012 Evaluating and Managing Precocious Puberty and PCOS

Case

Page 44: M. Jennifer Abuzzahab,MD 1 June 2012 Evaluating and Managing Precocious Puberty and PCOS

Conclusions

Normal timing and cadence of pubertal development

AdrenarchePubertyMenarche 2-21/2 years after breast development

Steroidogenesis altered by obesityLeptinInsulinAromatase in adipocytes

Identify when to refer to a specialistPuberty before 8yo (girls), 9yo (boys)BA more than 2 years advanced